News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Plexus Ventures Assists Cynata Therapeutics in the Out-Licensing of Cymerus™ Technology to FUJIFILM
Tokyo, Japan - Plexus Ventures is pleased to announce the successful completion of an out-licensing project on behalf of Cynata Therapeutics Ltd. Plexus provided professional services to Cynata in the out-licensing of its lead product, CYP-001, to FUJIFILM...
Plexus Ventures Assists Celon Pharma to Out-License Generic Advair® Diskus® for France
London, United Kingdom - Plexus Ventures is pleased to announce it served as advisor to Celon Pharma SA and Polfarmex SA in the out-licensing of Salmex® Orbicel® (fluticasone/salmeterol), a generic version of GSK’s Advair® Diskus®, to an undisclosed company for...
Events
JPM - San Francisco
January 12 – 15 , 2026
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.